Multi‐Chambered Core/Shell Supraparticles for Real‐Time, Full‐Time Diagnosis and Treatment Integration of Tumors
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202401749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Degang Kong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, China. Hauptthemen laut MEDLINE: Doxorubicin, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
To a certain extent, theranostic nanoplatforms promote tumor treatment efficiency. However, timely monitoring of the critical stages and signal sustainability of the entire process is challenging. In this study, multi‐chambered core/shell magnetic nanoparticles (MC‐MNPs) as drug and imaging agent multi‐loaded nanocarriers with a synergistic release function are reported. Supraparticles with stable chambers are formed by the supercooling self‐assembly of several core/shell magnetic nanoparticles composed of amphiphilic copolymers as the core and hydrophilic magnetic iron oxide nanoparticles as the shell. Desalinized doxorubicin and coumarin 6 are stored in different cavities of nanocarriers, and chitosan is used as an outer encapsulation layer. Based on their construction properties, MC‐MNPs can exhibit gradient‐degraded and steady‐released controllability in the tumor environment. Furthermore, real‐time accumulation situations and full‐time diagnostic signals of nanocarriers are thoroughly demonstrated using fluorescence imaging and T 2 ‐weighted magnetic resonance imaging before and after magnetic hyperthermia in targeted tumors under an alternating magnetic field. Thus, MC‐MNPs as theranostic nanocarriers exhibit great potential for the timely monitoring and full‐time guidance of tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, China.
ORCID-Profile: Xiaotong Zheng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
Zitieren
APA
Kong, D., Zheng, X., Ding, K., Zhong, R., Zhang, Z., Wang, Q., Dong, C., Zheng, Z., Li, X., Weng, J., & Zhou, S. (2025). Multi‐Chambered Core/Shell Supraparticles for Real‐Time, Full‐Time Diagnosis and Treatment Integration of Tumors. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401749
Vancouver
Kong D, Zheng X, Ding K, Zhong R, Zhang Z, Wang Q, et al. Multi‐Chambered Core/Shell Supraparticles for Real‐Time, Full‐Time Diagnosis and Treatment Integration of Tumors. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202401749
BibTeX
@article{Kong2025,
author = {Kong, Degang and Zheng, Xiaotong and Ding, Kai and Zhong, Run and Zhang, Zhao and Wang, Qingyi and Dong, Chunxiu and Zheng, Zhiwen and Li, Xiaohong and Weng, Jie and Zhou, Shaobing},
title = {Multi‐Chambered Core/Shell Supraparticles for Real‐Time, Full‐Time Diagnosis and Treatment Integration of Tumors},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202401749}
}
EUVIMED